IPM Presenting at CROI 2015
Connect with IPM in Seattle Feb. 23-26 at the 2015 annual Conference on Retroviruses and Opportunistic Infections (CROI), where researchers from around the world will share the latest progress on HIV/AIDS and related infectious diseases.
IPM will be presenting on safety and pharmacokinetics studies of its monthly vaginal ring that provides sustained release of an ARV drug called dapivirine. The dapivirine ring is also being evaluated in two parallel Phase III trials to determine whether it is safe and effective in preventing HIV in women.
Thurs., Feb. 26
2:30pm – 4pm, Poster Hall
P-H4: Pharmacokinetics in Compartments and Reservoirs and of Novel Formulations
- 524. Local and Systemic Pharmacokinetic Profile of Dapivirine Vaginal Ring-004 When Used Continuously Over Various Periods up to Twelve Weeks
P-V6: HIV Prevention, Miscellaneous
- 995. Female Condom Functionality in the Presence of a Vaginal Ring